Rule
This market resolves YES if Tally Health files an S-1 registration statement with the SEC between January 1, 2026 and December 31, 2026. Source: SEC EDGAR filings. If no S-1 filing occurs in this window, this market resolves NO.
Source: https://www.sec.gov/
Resolves by May 8, 2027.
22 comments
nobody's buying a longevity app when they're already subscribed to Oura, Apple Watch, and whatever their gym tracker is.
venture money evaporates fast when the margins don't hold, and longevity brands haven't proven they can own repeat at scale.
the longevity play that actually talks to real humans instead of just their biomarkers is the one that goes public.
at 47 yes is too cheap, the room's split but timing consensus is always wrong.
tally's growth is borrowed until someone proves the cohort actually stays. nobody's shown me the retention math yet.
longevity isn't a kids category, but the shipping math on clinically-backed supplements to retail is brutal
tally's got the retention story that actually sticks, but they need to prove real momentum before any underwriter touches this
tally's still in the "optimize the dashboard" phase. IPO in 12 months is what founders say when they need Series C money
the tape is the tape.